Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells

Brian J. Czerniecki, Calvin S. Carter, Licia Rivoltini, +8

The Journal of Immunology

Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models

Christopher A. Benetatos, Yasuhiro Mitsuuchi, Jennifer M. Burns, +18

Molecular Cancer Therapeutics

Chemoprevention StrategyApoptosisImmunologyCell DeathTumor Biology +20

A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma

Ravi K. Amaravadi, Russell J. Schilder, Lainie P. Martin, +4

Molecular Cancer Therapeutics

Surgical OncologySmac-mimetic BirinapantImmunologyPathologyPharmacotherapy +15

CD4+ T Cells in Adoptive Immunotherapy and the Indirect Mechanism of Tumor Rejection

Peter A. Cohen, Liaomin Peng, Gregory E. Plautz, +3

Critical Reviews in Immunology

T-regulatory CellImmunologyAntigen ProcessingImmune Cell TherapyIndirect Mechanism +16

Calcium Mobilization in Human Myeloid Cells Results in Acquisition of Individual Dendritic Cell-Like Characteristics Through Discrete Signaling Pathways

Gary K. Koski, Gretchen N. Schwartz, David Weng, +4

The Journal of Immunology

ImmunologyImmunologic MechanismImmunotherapyCellular PhysiologyCalcium Mobilization +17

A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors

David Weng, P. Masci, Susan F. Radka, +10

Molecular Cancer Therapeutics

Calcium Ionophore-Treated Myeloid Cells Acquire Many Dendritic Cell Characteristics Independent of Prior Differentiation State, Transformation Status, or Sensitivity to Biologic Agents

Gary K. Koski, Gretchen N. Schwartz, David Weng, +5

Blood

Patient Attitudes Regarding the Cost of Illness in Cancer Care

Barry Meisenberg, Ashley Varner, Erin M. Ellis, +4

The Oncologist

Inhibition of the conversion of 3T3 fibroblast clones to adipocytes by dehydroepiandrosterone and related anticarcinogenic steroids.

Gary Gordon, John A. Newitt, Lisa M. Shantz, +2

PubMed

Food IntakeRelated Anticarcinogenic SteroidsOxidative StressMetabolic SyndromeFibroblast Clones +14

An open‐label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer

Phuong K. Morrow, Rashmi K. Murthy, Joe Ensor, +7

Cancer

Tumor BiologySurgical OncologyOncologyMetastatic Breast CancerBreast Oncology +12